In ₹ Crore except Per Share Latest Annual	GODREJCP FY26	HINDUNILVR FY26	DABUR FY26	JYOTHYLAB FY25	Peer Average
Valuation — at last close
P/E	46.01×	29.03×	34.61×	◆ 17.35×	27.00× +70%
P/B	6.77×	8.96×	5.75×	◆ 3.14×	5.95× +14%
EV/EBITDA	27.54×	28.53×	25.25×	◆ 11.67×	21.82× +26%
Market Cap	₹85,642 Cr	₹4.37L Cr	₹65,627 Cr	₹6,428 Cr	₹1.70L Cr -49%
Growth
Revenue CAGR 3Y	4.46%	2.10%	4.59%	◆ 9.03%	5.24% -15%
Revenue CAGR 5Y	6.60%	6.51%	6.65%	◆ 10.72%	7.96% -17%
Net Income CAGR 3Y	3.02%	14.08%	3.18%	◆ 32.53%	16.60% -82%
Revenue YoY (latest Q)	◆ 15.37%	12.22%	10.57%	1.06%	7.95% +93%
Net Income YoY (latest Q)	13.84%	3.79%	◆ 15.32%	-2.41%	5.57% +149%
Profitability
EBITDA Margin	20.79%	◆ 23.35%	18.59%	17.55%	19.83% +5%
Net Income Margin	12.26%	◆ 23.36%	14.16%	13.01%	16.84% -27%
Return on Common Equity	15.10%	◆ 30.65%	17.06%	19.10%	22.27% -32%
Return on Capital Employed	◆ 21.91%	21.52%	16.42%	21.63%	19.86% +10%
Return on Assets	9.08%	◆ 18.87%	11.09%	14.55%	14.84% -39%
Credit & Quality
Total Debt/Equity	0.33×	◆ 0.00×	0.09×	0.00×	0.03× +1000%
Interest Coverage	8.71×	33.47×	13.64×	◆ 74.78×	40.63× -79%
Scale — latest FY
Revenue / Total Income	₹15,178 Cr	₹64,468 Cr	₹13,193 Cr	₹2,847 Cr	₹26,836 Cr -43%
Net Income	₹1,861 Cr	₹15,059 Cr	₹1,869 Cr	₹370 Cr	₹5,766 Cr -68%
Total Assets	₹21,334 Cr	₹79,752 Cr	₹17,480 Cr	₹2,691 Cr	₹33,308 Cr -36%
EPS	₹18.19	₹64.01	₹10.69	₹10.09	₹28.26 -36%
Book Value per Share	₹123.66	₹207.4	₹64.38	₹55.81	₹109.2 +13%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.